[
    {
        "drugresponse_id": "551667",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "HEC-1-A",
        "VALUE": "8.56",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0293",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551702",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "JHUEM-2",
        "VALUE": "8.67",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_4656",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551851",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "8.49",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551854",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "8.72",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551855",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNU-449",
        "VALUE": "8.13",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0454",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551667",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "HEC-1-A",
        "VALUE": "8.56",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0293",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Chemically-Induced disorders",
        "Disease_name": "Alcoholic Intoxication, Chronic",
        "Phase": "1"
    },
    {
        "drugresponse_id": "551702",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "JHUEM-2",
        "VALUE": "8.67",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_4656",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Chemically-Induced disorders",
        "Disease_name": "Alcoholic Intoxication, Chronic",
        "Phase": "1"
    },
    {
        "drugresponse_id": "551851",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "8.49",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Chemically-Induced disorders",
        "Disease_name": "Alcoholic Intoxication, Chronic",
        "Phase": "1"
    },
    {
        "drugresponse_id": "551854",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "8.72",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Chemically-Induced disorders",
        "Disease_name": "Alcoholic Intoxication, Chronic",
        "Phase": "1"
    },
    {
        "drugresponse_id": "551855",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNU-449",
        "VALUE": "8.13",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0454",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Chemically-Induced disorders",
        "Disease_name": "Alcoholic Intoxication, Chronic",
        "Phase": "1"
    },
    {
        "drugresponse_id": "386629",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386630",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386769",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "7.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386778",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "7.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386790",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386796",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386840",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "MFE-280",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1405",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386908",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SK-HEP-1",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0525",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386919",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "8.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386920",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SNU-387",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0250",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386921",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SNU-423",
        "VALUE": "7.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0366",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386922",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SNU-449",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0454",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386926",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386964",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "COLO-684",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1132",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "387024",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "387030",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "387070",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "EN",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2034",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "387090",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "JHH-7",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2805",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386629",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386630",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386769",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "7.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386778",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "7.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386790",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386796",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386840",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "MFE-280",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1405",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386908",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SK-HEP-1",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0525",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386919",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "8.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386920",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SNU-387",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0250",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386921",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SNU-423",
        "VALUE": "7.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0366",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386922",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SNU-449",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0454",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386926",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "386964",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "COLO-684",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1132",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "387024",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "387030",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "387070",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "EN",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2034",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "387090",
        "COMPOUND_NAME": "Daporinad",
        "CELL_LINE_NAME": "JHH-7",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL566757",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2805",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "KPBNHDGDUADAGP-VAWYXSNFSA-N",
        "COMPOUND_CLASS": "Enzyme inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "379227",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379228",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "C-4-I",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2253",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379229",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379450",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379467",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379490",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "7.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379502",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "7.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379511",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "HT-3",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1293",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379655",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SK-HEP-1",
        "VALUE": "7.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0525",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379667",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "7.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379668",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SNU-387",
        "VALUE": "7.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0250",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379669",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SNU-423",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0366",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379674",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379721",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "COLO-684",
        "VALUE": "7.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1132",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379736",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379806",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "RL95-2",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0505",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379808",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SiHa",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0032",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379809",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379815",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "7.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379860",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "EN",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2034",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379884",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "JHH-2",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2786",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379886",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "JHH-6",
        "VALUE": "7.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2788",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379898",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "MS751",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_4996",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379922",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "7.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379962",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "HeLa",
        "VALUE": "7.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0030",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Adenocarcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379967",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "JHH-1",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2785",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379227",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379228",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "C-4-I",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2253",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379229",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379450",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379467",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379490",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "7.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379502",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "7.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379511",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "HT-3",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1293",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379655",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SK-HEP-1",
        "VALUE": "7.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0525",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379667",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "7.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379668",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SNU-387",
        "VALUE": "7.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0250",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379669",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SNU-423",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0366",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379674",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379721",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "COLO-684",
        "VALUE": "7.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1132",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379736",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379806",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "RL95-2",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0505",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379808",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SiHa",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0032",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379809",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379815",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "7.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379860",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "EN",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2034",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379884",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "JHH-2",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2786",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379886",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "JHH-6",
        "VALUE": "7.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2788",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379898",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "MS751",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_4996",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379922",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "7.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379962",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "HeLa",
        "VALUE": "7.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0030",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Adenocarcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "379967",
        "COMPOUND_NAME": "Dinaciclib",
        "CELL_LINE_NAME": "JHH-1",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL2103840",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2785",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "PIMQWRZWLQKKBJ-SFHVURJKSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "1"
    },
    {
        "drugresponse_id": "551667",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "HEC-1-A",
        "VALUE": "8.56",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0293",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551702",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "JHUEM-2",
        "VALUE": "8.67",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_4656",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551851",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "8.49",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551854",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "8.72",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "551855",
        "COMPOUND_NAME": "AZD0530",
        "CELL_LINE_NAME": "SNU-449",
        "VALUE": "8.13",
        "METRIC": "pEC50",
        "DATASET": "CCLE_NP24",
        "Pubmed_ID": "22460905",
        "PUBCHEM_ID": "",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0454",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398060",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398061",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "C-4-I",
        "VALUE": "7.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2253",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398062",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398128",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "SW756",
        "VALUE": "7.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1727",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398295",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398312",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398335",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "8.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398347",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "7.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398356",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "HT-3",
        "VALUE": "7.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1293",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398425",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "MFE-296",
        "VALUE": "7.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1406",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398537",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "8.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398589",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "COLO-684",
        "VALUE": "7.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1132",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398608",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "C3A",
        "VALUE": "7.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1098",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatoblastoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398682",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "RL95-2",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0505",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398685",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398692",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398769",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "JHH-2",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2786",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398770",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "JHH-4",
        "VALUE": "7.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2787",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398782",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "MFE-319",
        "VALUE": "7.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2112",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398809",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "SISO",
        "VALUE": "7.77",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2193",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Adenocarcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398811",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "7.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398857",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "huH-1",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2956",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398858",
        "COMPOUND_NAME": "SN-38",
        "CELL_LINE_NAME": "JHH-1",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "104842.0",
        "CHEMBL_ID": "CHEMBL837",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2785",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "FJHBVJOVLFPMQE-QFIPXVFZSA-N",
        "COMPOUND_CLASS": "Cytochrome inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Colorectal Carcinoma",
        "Phase": "2"
    },
    {
        "drugresponse_id": "367705",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368164",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368171",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368235",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368310",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "7.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368401",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "MFE-319",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2112",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368429",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "367705",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368164",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368171",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368235",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368310",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "7.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368401",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "MFE-319",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2112",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368429",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "367705",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368164",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368171",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368235",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368310",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "7.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368401",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "MFE-319",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2112",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "368429",
        "COMPOUND_NAME": "BI-2536",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL513909",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "XQVVPGYIWAGRNI-JOCHJYFZSA-N",
        "COMPOUND_CLASS": "Epigenetic regulator inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Pancreatic Neoplasm",
        "Phase": "2"
    },
    {
        "drugresponse_id": "352793",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353068",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353253",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "SK-HEP-1",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0525",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353273",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353340",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353420",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353505",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "JHH-2",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2786",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353517",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "MFE-319",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2112",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "352793",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353068",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353253",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "SK-HEP-1",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0525",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353273",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353340",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353420",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353505",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "JHH-2",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2786",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "353517",
        "COMPOUND_NAME": "Dactolisib",
        "CELL_LINE_NAME": "MFE-319",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL1879463",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2112",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "JOGKUKXHTYWRGZ-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Islet Cell Tumor",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407699",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407700",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C-4-I",
        "VALUE": "7.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2253",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407701",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407936",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407953",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "7.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407976",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407988",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "7.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408177",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "SNU-423",
        "VALUE": "7.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0366",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408182",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408250",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408253",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C3A",
        "VALUE": "7.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1098",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatoblastoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408330",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408337",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "7.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407699",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407700",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C-4-I",
        "VALUE": "7.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2253",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407701",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407936",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407953",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "7.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407976",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407988",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "7.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408177",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "SNU-423",
        "VALUE": "7.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0366",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408182",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408250",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408253",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C3A",
        "VALUE": "7.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1098",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatoblastoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408330",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "SKG-IIIa",
        "VALUE": "7.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1704",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408337",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "TC-YIK",
        "VALUE": "7.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1737",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Small Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407699",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "7.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407700",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C-4-I",
        "VALUE": "7.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_2253",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407701",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407936",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407953",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "7.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407976",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "407988",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "7.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408177",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "SNU-423",
        "VALUE": "7.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0366",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408182",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "7.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408250",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "7.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    },
    {
        "drugresponse_id": "408253",
        "COMPOUND_NAME": "Luminespib",
        "CELL_LINE_NAME": "C3A",
        "VALUE": "7.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL252164",
        "MAX_PHASE": "Phase II",
        "RRID": "CVCL_1098",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatoblastoma",
        "INCHI_KEY": "NDAZATDQFDPQBD-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Cytosolic inhibitors",
        "Disease_class": "Digestive system",
        "Disease_name": "Gastrointestinal Stromal Tumors",
        "Phase": "2"
    }
]